Santiago Gisler,  —

Verona Pharma started a Phase 2b dose-ranging study testing the safety and efficacy of nebulized ensifentrine (RPL554) as an add-on to a standard long-acting bronchodilator in people with moderate to severe chronic obstructive pulmonary disease (COPD), the company announced. The inhaled dual inhibitor ensifentrine targets the enzymes phosphodiesterase…

Video telehealth rehabilitation reduced the rates that patients with chronic obstructive pulmonary disease (COPD) had to be readmitted within 30 days after they were hospitalized for a pulmonary exacerbation, according to a study. The findings were published in the American Journal of Respiratory and Critical Care Medicine in a…

The Loop wristband device, designed to remotely monitor the condition of patients with chronic diseases such as chronic obstructive pulmonary disease (COPD), received marketing clearance from the U.S. Food and Drug Administration (FDA), announced the device’s developer, Spry Health. Loop is a wearable technology that measures pulse…

A new tool identifying broad areas of need by patients receiving palliative or end-of-life care may improve personalized care for patients with advanced chronic obstructive pulmonary disease (COPD) and promote more holistic care. The study detailing the development of SNAP, as the tool is called, was published in the…

Differences in DNA may explain lung health and the risk of chronic obstructive pulmonary disease (COPD) in both smokers and non-smokers and could help in the future development of preventive and therapeutic strategies against COPD, a large-scale study reports. The study, “New genetic signals for lung function highlight pathways and…

Patients with chronic obstructive pulmonary disease (COPD) are unaware of their increased lung cancer risk compared with the general population — attributing their chest symptoms to factors other than potential cancer signs, according to a study. The researchers recommended campaigns to raise awareness about this risk since early lung cancer detection…

Statins, commonly used to lower blood cholesterol levels, can help chronic obstructive pulmonary disease (COPD) patients by preventing or treating COPD-related comorbidities, and by improving patients’ lung function and exercise capacity, according to a meta-analysis study of existing research data. Results from the meta-analysis, titled “Effectiveness of long-term using…

People with chronic obstructive pulmonary disease (COPD) have an increased risk of severe illness, hospitalization, and death if they become infected with the influenza virus, according to a Canadian study. Researchers emphasize that getting a flu vaccine can significantly reduce these risks. The study, published in the journal…

Data from a three-day Phase 2 clinical trial offered positive results for nebulized ensifentrine (RPL544) as an add-on treatment for chronic obstructive pulmonary disease (COPD), its developer Verona Pharma announced. Ensifentrine is an inhibitor of phosphodiesterase (PDE) proteins PDE3 and PDE4, which are involved in smooth muscle contraction and immune cell-derived inflammation, respectively.

Cognitive behavioral therapy (CBT) intervention can alleviate anxiety in people with chronic obstructive pulmonary disease (COPD), and reduce long-term hospital costs, a study shows. The results were published in the journal ERJ Open Research, in an article titled “Randomised controlled trial of cognitive behavioural therapy in…